We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22.9B
AUM Growth
-$4.32B
Cap. Flow
-$424M
Cap. Flow %
-1.85%
Top 10 Hldgs %
13.89%
Holding
1,428
New
104
Increased
438
Reduced
568
Closed
134

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
BMY icon
Bristol-Myers Squibb
BMY
+$59.2M
3
HUM icon
Humana
HUM
+$54.1M
4
EMR icon
Emerson Electric
EMR
+$47.7M
5
TGT icon
Target
TGT
+$45.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$68.5M
2
SYK icon
Stryker
SYK
+$50.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$46.2M
4
NVDA icon
NVIDIA
NVDA
+$44.1M
5
SWK icon
Stanley Black & Decker
SWK
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 21.77%
2 Healthcare 16.07%
3 Financials 11.39%
4 Consumer Discretionary 9.78%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MET icon
551
MetLife
MET
$62.4B
$5.62M 0.02%
136,781
-407
-0.3% -$17.5K
RGA icon
552
Reinsurance Group of America
RGA
$16.2B
$5.58M 0.02%
39,765
-12,600
-24% -$1.79M
CXW icon
553
CoreCivic
CXW
$3.5B
$5.56M 0.02%
311,700
-12,204
-4% -$268K
SCZ icon
554
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.8B
$5.55M 0.02%
107,020
+12,560
+13% +$703K
MTZ icon
555
MasTec
MTZ
$17.9B
$5.5M 0.02%
135,566
-12,525
-8% -$539K
ICLR icon
556
Icon
ICLR
$13.3B
$5.48M 0.02%
42,409
-5,591
-12% -$772K
ENB icon
557
Enbridge
ENB
$106B
$5.47M 0.02%
176,044
+5,645
+3% +$182K
AXDX
558
DELISTED
Accelerate Diagnostics
AXDX
$5.46M 0.02%
47,487
+7,117
+18% +$1.05M
EXAS
559
DELISTED
Exact Sciences
EXAS
$5.45M 0.02%
86,400
-12,000
-12% -$824K
CHRW icon
560
C.H. Robinson
CHRW
$18.4B
$5.44M 0.02%
64,695
-114,700
-64% -$10.3M
BAP icon
561
Credicorp
BAP
$29.6B
$5.41M 0.02%
24,417
-10,388
-30% -$2.3M
STRA icon
562
Strategic Education
STRA
$1.85B
$5.4M 0.02%
+47,650
New +$6.07M
GLW icon
563
Corning
GLW
$124B
$5.4M 0.02%
178,841
+1,540
+0.9% +$49.1K
HIG icon
564
Hartford Financial Services
HIG
$36.8B
$5.36M 0.02%
+120,609
New +$5.43M
NBL
565
DELISTED
Noble Energy, Inc.
NBL
$5.34M 0.02%
284,429
+2,228
+0.8% +$57K
IVZ icon
566
Invesco
IVZ
$13.6B
$5.33M 0.02%
318,523
-383,600
-55% -$7.68M
GHDX
567
DELISTED
Genomic Health, Inc.
GHDX
$5.31M 0.02%
+82,500
New +$5.78M
OXM icon
568
Oxford Industries
OXM
$444M
$5.29M 0.02%
74,500
-6,400
-8% -$519K
COUP
569
DELISTED
Coupa Software Incorporated
COUP
$5.26M 0.02%
83,617
+5,600
+7% +$354K
RRR icon
570
Red Rock Resorts
RRR
$3.18B
$5.23M 0.02%
257,600
-23,400
-8% -$551K
ESNT icon
571
Essent Group
ESNT
$6.13B
$5.22M 0.02%
152,700
+80,300
+111% +$3.07M
OSIS icon
572
OSI Systems
OSIS
$3.23B
$5.17M 0.02%
70,500
+35,700
+103% +$2.58M
OUT icon
573
Outfront Media
OUT
$4.95B
$5.15M 0.02%
288,639
-59,333
-17% -$1.13M
BIG
574
DELISTED
Big Lots, Inc.
BIG
$5.14M 0.02%
177,900
-9,800
-5% -$381K
SYNA icon
575
Synaptics
SYNA
$3.81B
$5.12M 0.02%
137,600
+51,000
+59% +$1.92M

Similar funds

Axa's Q4 2018 Portfolio in Review

As of Q4 2018, Axa held 1,428 positions worth $22.9B, down 16% from $27.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q4 2018 filing shows 104 new, 438 increased, 568 reduced and 134 closed positions. Its largest new stake was Linde: 3,157,617 shares worth $493M. The largest sale was Hologic, an estimated $68.5M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2018 buy was Linde: 3,157,617 shares worth $493M.
  • Axa added most to Bristol-Myers Squibb in Q4 2018, an estimated $59.2M increase.
  • Axa's biggest Q4 2018 reduction was Hologic, cutting an estimated $68.5M.
  • Axa fully exited Praxair Inc in Q4 2018, selling an estimated $25.6M.
  • Axa's ten largest holdings make up 14% of its $22.9B portfolio in Q4 2018.
  • Axa opened 104 new positions and closed 134 in Q4 2018.
  • Axa's portfolio value fell 16% quarter-over-quarter to $22.9B.

Based on Axa's 13F filing for Q4 2018, filed 13 Feb 2019.